- Home
- COP vs MDT Comparison
COP vs MDT Comparison
Compare COP & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COP | MDT |
|---|---|---|
| Founded | 1917 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Integrated oil Companies | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.6B | 114.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | COP | MDT |
|---|---|---|
| Price | $97.10 | $100.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 18 | 18 |
| Target Price | ★ $114.94 | $108.63 |
| AVG Volume (30 Days) | 6.8M | ★ 7.7M |
| Earning Date | 11-06-2025 | 11-18-2025 |
| Dividend Yield | ★ 3.47% | 2.82% |
| EPS Growth | N/A | ★ 12.98 |
| EPS | ★ 7.08 | 3.69 |
| Revenue | ★ $61,280,000,000.00 | $34,758,000,000.00 |
| Revenue This Year | $10.27 | $8.60 |
| Revenue Next Year | N/A | $5.83 |
| P/E Ratio | ★ $13.68 | $27.31 |
| Revenue Growth | ★ 7.65 | 5.34 |
| 52 Week Low | $79.88 | $79.29 |
| 52 Week High | $106.20 | $106.33 |
Technical Indicators
Market Signals| Indicator | COP | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 68.99 | 55.46 |
| Support Level | $92.18 | $101.58 |
| Resistance Level | $95.07 | $102.49 |
| Average True Range (ATR) | 2.13 | 1.78 |
| MACD | 0.83 | -0.43 |
| Stochastic Oscillator | 93.51 | 23.61 |
Price Performance
Historical ComparisonAbout COP ConocoPhillips
ConocoPhillips is a US-based independent exploration and production firm. Its operations are primarily in Alaska and the Lower 48, with footprints in Canada, Europe, Asia-Pacific, the Middle East, and Africa. It also has substantial integrated LNG production and marketing activities across geographies.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.